Comparing surgical methods for treating granulomatous mastitis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of different surgical approaches on the recurrence rate and aesthetic outcomes in patients with granulomatous mastitis. Participants are divided into two groups: one receiving traditional surgery and the other undergoing breast-conserving plastic surgery. The study aims to compare postoperative recurrence rates, adverse reactions, aesthetic results, and patient satisfaction between the two surgical methods. By exploring these outcomes, the research seeks to provide clearer guidance for clinical decision-making in the treatment of this rare breast condition.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Only the subjects who meet all the following criteria may be included in this study:

1. Ability to understand the study procedures and contents, and willingness to voluntarily sign the written informed consent form;
2. 18≤Age≤75 years old, female;
3. Histologically confirmed granulomatous mastitis;
4. low and moderate risk for anesthesia.

Exclusion Criteria:

The subjects who meet any of the following criteria shall not be included in this study:

1. Absolute and relative contraindication for surgery;
2. Previous history of breast cancer or other malignancies;
3. Pregnancy;
4. Any serious complications which caused patients not suitable to participate this study.

Where it's running

• Hubei Cancer Hospital
  Wuhan, Hubei, China Recruiting

Study contacts

• Study coordinator: Hongmei Zheng, Doctor
• Email: zhenghongmeicj@163.com
• Phone: 18971624606

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Idiopathic granulomatous mastitis patient registry

  This registry collects real-world information from adults with idiopathic granulomatous mastitis to understand how the condition presents, is diagnosed, and progresses in Europe.

  Recruiting at 2 sites European Breast Cancer Research Association of Surgical Trialists · Düsseldorf, North Rhine-Westphalia and 1 other locations · NCT07422870

• Gut microbiome differences in people on abemaciclib who do or don't get diarrhea

  This project will compare gut bacteria in people with HR-positive breast cancer who are taking abemaciclib to see if differences are linked to developing diarrhea.

  Recruiting Hubei Cancer Hospital · Wuhan, Hubei · NCT07264998

• Gut bacteria and diarrhea in breast cancer patients on pyrotinib

  This study will see if gut bacteria differ between breast cancer patients on pyrotinib who develop diarrhea and those who don’t, to understand why this side effect happens.

  Recruiting Hubei Cancer Hospital · Wuhan, Hubei · NCT07264985

• Monitoring blood markers during DIEP flap breast reconstruction

  We will see if measuring inflammation and oxidative stress markers in blood before and during the first 72 hours after DIEP flap reconstruction helps map recovery patterns for women having immediate breast reconstruction after mastectomy.

  Recruiting Hubei Cancer Hospital · Wuhan, Hubei · NCT07263347

• Minimal-invasive DNA test on nipple fluid to tell benign from malignant nipple discharge

  This study tests whether DNA analysis of nipple fluid can help tell benign from malignant causes of pathologic nipple discharge in adults undergoing diagnostic breast surgery.

  Recruiting Hubei Cancer Hospital · Wuhan, Hubei · NCT07250204

• Combining SBRT, chemotherapy, and AK112 for treating luminal-type breast cancer

  This study is testing whether combining a type of radiation therapy, chemotherapy, and a new immunotherapy can help people with luminal-type breast cancer respond better to treatment.

  Recruiting Phase 2 Hubei Cancer Hospital · Wuhan, Hubei · NCT06402435

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.